Effects of a single sickling event on the mechanical fragility of sickle cell trait erythrocytes

Hemoglobin

Volumn 34, Issue 1, 2010, Pages 24-36

  Presley, Tennille D ^a   Perlegas, Andreas S ^a   Bain, Lauren E ^a   Ballas, Samir K ^b   Nichols, James S ^c   Sabio, Hernan ^d   Gladwin, Mark T ^e,f   Kato, Gregory J ^g   Kim Shapiro, Daniel B ^a  

^a WAKE FOREST UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

^g NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Fragility; Hemoglobin (Hb); Hemolysis; Sickle cell disease

Indexed keywords

HEMOGLOBIN;

ARTICLE; ERYTHROCYTE; ERYTHROCYTE DEFORMABILITY; FLOW KINETICS; HEMOLYSIS; HYPOXIC CELL; OXIDATIVE STRESS; OXYGEN SATURATION; POLYMERIZATION; SHEAR STRESS; SICKLE CELL TRAIT;

ERYTHROCYTES; HEMOGLOBIN, SICKLE; HEMOLYSIS; HUMANS; SICKLE CELL TRAIT;

EID: 76449089281     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630260903546999     Document Type: Article

References (63)

1. Ingram VM. A specific chemical difference between the globins of normal human and sickle cell anaemia haemoglobin. Nature. 1956;178(4537):792-794.
2. Murayama M. Molecular mechanism of red cell "sickling." Science. 1966;153(732):145-149.
3. Gulley ML, Ross DW, Feo C, Orringer EP. The effect of cell hydration on the deformability of normal and sickle erythrocytes. Am J Hematol. 1982;13(4):283-291.
4. MacCallum RN, Lynch EC, Hellums JD, Alfrey Jr, CP. Fragility of abnormal erythrocytes evaluated by response to shear stress. J Lab Clin Med. 1975;85(1):67-74.
5. Nevaril CG, Lynch EC, Alfrey Jr, CP, Hellums JD. Erythrocyte damage and destruction induced by shearing stress. J Lab Clin Med. 1968;71(5):784-790.
6. Padilla F, Bromberg PA, Jensen WN. The sickle-unsickle cycle: a cause of cell fragmentation leading to permanently deformed cells. Blood. 1973;41(5):653-660.
7. Mohandas N, Hebbel RP. Erythrocyte deformability, fragility, and rheology. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, Eds. Sickle Cell Disease. New York: Raven Press. 1994:205-216.
8. Eaton WA, Hofrichter J. Sickle cell hemoglobin polymerization. Adv Protein Chem. 1990;40:63-279.
9. Noguchi CT, Schechter AN. Sickle hemoglobin polymerization in solution and in cells. Annu Rev Biophys Biol. 1985;14(1):239-263.
10. Shen SC, Castle WB, Fleming EM. Experimental and clinical observations of increased mechanical fragility of erythrocytes. Science. 1944;100(2600):387- 389.
11. Bensinger TA, Washington DC, Gillette MD. Hemolysis in sickle cell disease. Arch Intern Med. 1974;133(4):624-631.
12. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin-A novel mechanism of human disease. JAMA. 2005;293(13):1653-1662.
13. Schechter AN, Gladwin MT. Hemoglobin and the paracrine and endocrine functions of nitric oxide. N Engl J Med. 2003;348(15):1483-1485.
14. Reiter CD, Wang XD, Tanus-Santos JE, et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med. 2002;8(12):1383-1389.
15. Reiter CD, Gladwin MT. An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy. Curr Opin Hematol. 2003;10(2):99-107.
16. Aslan M, Ryan TM, Adler B, et al. Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc Natl Acad Sci USA. 2001;98(26):15215-15220.
17. Minneci PC, Deans KJ, Zhi H, et al. Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. J Clin Invest. 2005;115(12):3409-3417.
18. Morris CR, Morris SM, Hagar W, et al. Arginine therapy -A new treatment for pulmonary hypertension in sickle cell disease? Am J Resp Crit Care. 2003;168(1):63-69.
19. Morris CR, Vichinsky EP, Kato GJ, Gladwin MT, Hazen S, Morris SM. Arginine metabolism, pulmonary hypertension, and sickle cell disease-In reply. JAMA. 2005;294(19):2433-2434.
20. Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004;350(9):886-895.
21. Nolan VG, Wyszynski DF, Farrer LA, Steinberg MH. Hemolysis-associated priapism in sickle cell disease. Blood 2005;106(9):3264-3267.
22. Alayash AI, Patel RP, Cashon RE. Redox reactions of hemoglobin and myoglobin: Biological and toxicological implications. Antioxid Redox Sign. 2001;3(2):313-327.
23. Alayash AI. Oxygen therapeutics: can we tame haemoglobin? Nat Rev Drug Discov. 2004;3(2):152-159.
24. Balla J, Jacob HS, Balla G, Nath K, Eaton JW, Vercellotti GM. Endothelial-cell heme uptake from heme-proteins-induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci USA. 1993;90(20):9285- 9289.
25. Jeney V, Balla J, Yachie A, et al. Pro-oxidant and cytotoxic effects of circulating heme. Blood. 2002;100(3):879-887.
26. Porto BN, Alves LS, Fernandez PL, et al. Heme induces neutrophil migration and reactive oxygen species generation through signaling pathways characteristic of chemotactic receptors. J Biol Chem. 2007;282(33):24430-24436.
27. Frei AC, Guo Y, Jones DW, et al. Vascular dysfunction in a murine model of severe hemolysis. Blood. 2008;112(2):398-405.
28. Liu SC, Zhai S, Palek J. Detection of hemin release during Hemoglobin-S denaturation. Blood. 1988;71(6):1755-1758.
29. Crosby WH. The metabolism of hemoglobin and bile pigment in hemolytic disease. Am J Med. 1955;18(1):112-122.
30. Kato GJ, Gladwin MT. Mechanisms and clinical complications of hemolysis in sickle cell disease and thalassemia. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, Eds. Disorders of Hemoglobin Genetics, Pathophysiology, and Clinical Management. New York: Cambridge University Press; 2009:201-224.
31. Eaton JW, Jacob HS, White JG. Membrane abnormalities of irreversibly sickled cells. Semin Hematol. 1979;16(1):52-64.
32. Kaul DK, Fabry ME, Nagel RL. Vasooclusion by sickle cells-evidence for selective trapping of dense red-cells. Blood. 1986;68(5):1162-1166.
33. McCurdy PR, Sherman AS. Irreversibly sickled cells and red-cell survival in sickle-cell anemia - study with both DF32P and CR-51. Am J Med. 1978;64(2):253-258.
34. Noguchi CT, Schechter AN. The intracellular polymerization of sickle hemoglobin and its relevance to sickle-cell disease. Blood. 1981;58(6):1057- 1068.
35. Rodgers G, Noguchi CT, Schechter AN. Irreversibly sickled erythrocytes in sickle cell anemia: a quantitative reappraisal. Am J Hematol. 1985;20(1):17-23.
36. Goodman SR. The irreversibly sickled cell: a perspective. Cell Mol Biol. 2004;50(1):53-58.
37. Hebbel RP, Eaton JW, Balasingam M, Steinberg MH. Spontaneous oxygen radical generation by sickle erythrocytes. J Clin Invest. 1982;70(6):1253-1259.
38. Hsu LL, Champion HC, Campbell-Lee SA, et al. Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Blood. 2007;109(7):3088-3098.
39. Wood KC, Hebbel RP, Lefer DJ, Granger DN. Critical role of endothelial cell-derived nitric oxide synthase in sickle cell disease-induced microvascular dysfunction. Free Radic Biol Med. 2006;40(8):1443-1453.
40. Hebbel RP. Beyond hemoglobin polymerization-the red-blood cell membrane and sickle disease pathophysiology. Blood. 1991;77(2):214-237.
41. Hebbel RP, Miller WJ. Phagocytosis of sickle erythrocytes - immunological and oxidative determinants of hemolytic-anemia. Blood. 1984;64(3):733-741.
42. Das SK, Nair RC. Superoxide-dismutase, glutathione-peroxidase, catalase and lipid-peroxidation of normal and sickled erythrocytes. Br J Haematol. 1980;44(1):87-92.
43. Jain SK, Shohet SB. A novel phospholipid in irrevresibly sickled cells - evidence for in vivo peroxidative membrane damage in sickle-cell disease. Blood. 1984;63(2):362-367.
44. Platt OS, Falcone JF, Lux SE. Molecular defects in the sickle erythrocyte skeleton-abnormal spectrin binding to sickle inside-out vesicles. J Clin Invest. 1985;75(1):266-271.
45. Rank BH, Carlsson J, Hebbel RP. Abnormal redox status of membrane-protein thiols in sickle erythrocytes. J Clin Invest. 1985;75(5):1531-1537.
46. Schwartz RS, Rybicki AC, Heath RH, Lubin BH. Protein 4.1 in sickle erythrocytes-evidence for oxidative damage. J Biol Chem. 1987;262(32):15666- 15672.
47. Shalev O, Hebbel RP. Catalysis of soluble hemoglobin oxidation by free iron on sickle red cell membranes. Blood. 1996;87(9):3948-3952.
48. Riceevans C, Omorphos SC, Baysal E. Sickle-cell membranes and oxidative damage. Biochem J. 1986;237(1):265-269.
49. Kuypers FA, Scott MD, Schott MA, Lubin B, Chiu DTY. Use of ektacytometry to determine red-cell susceptibility to oxidative stress. J Lab Clin Med. 1990;116(4):535-545.
50. Goldbloom RB, Fischer E, Reinhold J, Hsia DY. Studies on the mechanical fragility of erythrocytes: I. Normal values for infants and children. Blood. 1953;8(2):165-169.
51. Claster S, Vichinsky EP. Managing sickle cell disease. BMJ. 2003;327(7424):1151-1155.
52. Stroncek DF, Rainer T, Sharon V, et al. Sickle Hb polymerization in RBC components from donors with sickle cell trait prevents effective WBC reduction by filtration. Transfusion. 2002;42(11):1466-1472.
53. Gupta AK, Kirchner KA, Nicholson R, et al. Effects of a-thalassemia and sickle polymerization tendency on the urine-concentrating defect of individuals with sickle-cell trait. J Clin Invest. 1991;88(6):1963-1968.
54. Gupta AK, Kirchner KA, Nicholson R, et al. Hyposthenuria in sickle-cell trait (Hb AS) correlates with percent Hemoglobin S (Hb S). Clin Res. 1990;38(4):A985-A985.
55. Helzlsouer KJ, Hayden FG, Rogol AD. Severe metabolic complications in a cross-country runner with sickle-cell trait. JAMA. 1983;249(6):777-779.
56. Noguchi CT, Torchia DA, Schechter AN. Polymerization of hemoglobin in sickle trait erythrocytes and lysates. J Biol Chem. 1981;256(9):4168-4171.
57. Hedayati B, Anson K, Patel U. Focal renal infarction: an unusual cause of haematuria in a patient with sickle cell trait. Br J Radiol. 2007;80(953):e105-106.
58. Antonini E, Brunori M. Hemoglobin and Myoglobin in Their Reactions with Ligands. Amsterdam: North Holland Publishing Company. 1971.
59. Huang Z, Hearne L, Irby CE, King SB, Ballas SK, Kim-Shapiro DB. Kinetics of increased deformability of deoxygenated sickle cells upon oxygenation. Biophys J. 2003;85(4):2374-2383.
60. Huang Z, Louderback JG, King SB, Ballas SK, Kim-Shapiro DB. In vitro exposure to hydroxyurea reduces sickle red blood cell deformability. Am J Hematol. 2001;67(3):151-156.
61. Groner W, Mohandas N, Bessis M. New optical technique for measuring erythrocyte deformability with the ektacytometer. Clin Chem. 1980;26(10):1435-1442.
62. Mohandas N, Clark MR, Jacobs MS, Shohet SB. Analysis of factors regulating erythrocyte deformability. J Clin Invest. 1980;66(3):563-573. (Pubitemid 10053921)
63. Schubothe H, Fok FP. The quantitative estimation of mechanical haemolysis for clinical application. Br J Haematol. 1960;6(1):350-354.